- Home
- SILO vs GSIW Comparison
SILO vs GSIW Comparison
Compare SILO & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SILO | GSIW |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Apparel | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0M | 33.9M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | SILO | GSIW |
|---|---|---|
| Price | $0.40 | $0.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 130.5K | ★ 331.4K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $72,102.00 | ★ $5,368,221.00 |
| Revenue This Year | $1.86 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 283.23 |
| 52 Week Low | $0.36 | $0.09 |
| 52 Week High | $3.37 | $1.79 |
Technical Indicators
Market Signals| Indicator | SILO | GSIW |
|---|---|---|
| Relative Strength Index (RSI) | 35.52 | 40.08 |
| Support Level | $0.42 | $0.13 |
| Resistance Level | $0.46 | $0.15 |
| Average True Range (ATR) | 0.02 | 0.01 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 1.29 | 21.65 |
Price Performance
Historical ComparisonAbout SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.